PAFAGOLD M 500 combines Dapaflozin (10 mg) and Metformin SR (500 mg) to provide an effective solution for managing type 2 diabetes. This combination medication helps in controlling blood sugar levels, improving insulin sensitivity, and reducing the risk of diabetes-related complications.

How Does It Work?

• Dapaflozin: Inhibits the sodium-glucose co-transporter-2 (SGLT2) in the kidneys, preventing glucose reabsorption and promoting its excretion through urine.
• Metformin SR: Decreases hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake, providing sustained blood sugar control.

Uses of PAFAGOLD M 500

• Management of type 2 diabetes mellitus
• Improvement of glycemic control
• Reduction of postprandial blood sugar levels
• Decrease in the risk of cardiovascular events in diabetic patients

What is PAFAGOLD M 500?

PAFAGOLD M 500 is an oral antidiabetic medication that combines Dapaflozin, an SGLT2 inhibitor, and Metformin SR, a biguanide. This combination aims to provide comprehensive blood glucose management by targeting different mechanisms in the body.

Side Effects

• Hypoglycemia (when used with other antidiabetic agents)
• Gastrointestinal issues (nausea, diarrhea)
• Urinary tract infections
• Genital infections
• Dizziness
• Increased urination

Safety Information

• Dosage: Take as prescribed by your healthcare provider. Do not alter the dosage without medical advice.
• Precautions:
  • Monitor kidney function regularly.
  • Maintain proper hydration to prevent dehydration.
• Interactions: Inform your doctor about all medications and supplements you are taking to avoid potential interactions.
• Contraindications: Not suitable for patients with severe renal impairment, type 1 diabetes, or diabetic ketoacidosis.

If You Need More Information About  PAFAGOLD M 500  Click here